RAPID (Evaluating the Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents with Diabetes in Real World Practice).
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms RAPID
- Sponsors AstraZeneca
- 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2008 Planned end date changed to Dec 2007 as reported by ClinicalTrials.gov.
- 20 Sep 2007 New trial record.